(WAT)

Reporting relationship: SVP Waters Adv. Diagnostics
Issuer ticker: WAT
Reported as of: 25 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Feb 2026, 19:32:38 UTC
Prior SEC filing: 06 Feb 2026
Next SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Lynn, attorney-in-fact for Jianqing Bennett

Key filing fact

Jianqing Bennett filed Form 4 for WATERS CORP /DE/ (WAT) on 27 Feb 2026.

Key facts

This page summarizes Jianqing Bennett's Form 4 filing for WATERS CORP /DE/ (WAT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 Feb 2026, 19:32.

Change

Previous filing in this sequence was filed on 06 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001856691 Primary reporting owner

Bennett Jianqing

Relationship: SVP Waters Adv. Diagnostics
Address: 34 MAPLE STREET, MILFORD
Signature: /s/ Michael Lynn, attorney-in-fact for Jianqing Bennett
Signature date: 27 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WAT transaction

Common Stock

Award

Transaction value: $0
Shares: +986
Change %: +16%
Price: $0.000000
Shares after: 7,244
Date: 25 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WAT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +4,826
Change %
Price: $0.000000
Shares after: 4,826
Date: 25 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,826
Exercise price: $319.44
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement.

Footnote F2

The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.